Clinical Trial Update: Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated anti-inflammatory effects of intracoronary and intravenous abciximab administration during primary percutaneous coronary inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Abciximab (ReoPro) (abciximab)

Snippet

Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED